SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NKTR Drug delivery Company
An SI Board Since September 2005
Posts SubjectMarks Bans Symbol
507 31 0 NKTR
Emcee:  david nordic Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
207MLCO lowers estimates for Exubera and price target for NKTR, which they used to tuck-4/5/2007
206I guess the week of 3/19 had something like President's day Or MLK day??? NIan@SI-4/3/2007
205Link to Yahoo MB subject on scrip trends. Growing steadily, but still pretty tetuck-4/3/2007
204Seems as if there's one doctor and one patient that like Exubera! ;-) or sIan@SI-3/21/2007
203Nektar Initiates Phase 1 Clinical Program Evaluating NKTR-102 (PEG-irinotecan) fdavid nordic-3/18/2007
202Nektar starts early trial of cancer treatment Tuesday March 13, 4:39 pm ET Nekdavid nordic-3/13/2007
201>>Nektar Announces Financial Results for the Year and Fourth Quarter 2006 tuck-2/28/2007
200Nice to see the direct link between Shareholder Return and CEO compensation. [/Ian@SI-2/26/2007
199Pfizer Pitches Inhaled Insulin to Consumers, Risks Doctors' Ire By ShannonQualified Opinion-2/22/2007
198ARDM is pretty crispy, yes. But the program lives on. NVO bought the rights atuck-2/16/2007
197salvage something from the ARDM program ARDM is toast.technetium-2/16/2007
196I'll wait until after the call before doing any more writes.Ian@SI-2/15/2007
195Obviously, we aren't going to be looking too closely at the 4th Q. What'tuck-2/15/2007
194if it wasn't for Lance Armstrong, I wouldn't have had a clue as to what Ian@SI-2/15/2007
193Optimism pretty firm, but share price probably won't explode. This is why Ituck-2/15/2007
192Thanks, Tuck (eom)DewDiligence_on_SI-2/15/2007
191Tuck, How firm are you in your optimism re NKTR? So far I've either kept aIan@SI-2/15/2007
190Well, right, cuz Pfizer hasn't only just gotten started. Feel free to keep tuck-2/15/2007
189Exubera has had no impact to date on sales of injected insulin. (Source: Today’sDewDiligence_on_SI-1/31/2007
188Merrill: Nektar Therapeutics (NKTR, US$14.4, C-1-9) Reducing PO to $20 from $28tom pope-1/23/2007
187C/W's Najarian: Two Options with Upside Potential (NKTR, BDK) Options guru MLD38-1/18/2007
186Nektar Appoints Howard W. Robin President and CEO Monday January 8, 8:15 am ET david nordic-1/8/2007
185Judge Won't Stop Pfizer Sales of Exubera Thursday December 14, 11:14 am ET david nordic-12/14/2006
184Alkermes product not likely until late '09 at earliest: Snip from today'tuck-12/7/2006
18311:54 NKTR Nektar Therapeutics: WR Hambrecht estimates NKTR's value to PFE Saulamanca-12/4/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News